Increased activation of cGAS‐STING pathway enhances radiosensitivity of non‐small cell lung cancer cells

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma

(2021) Xueping Jiang et al.   Cell and Bioscience

Radiation-Induced Immunity and Toxicities: The Versatility of the cGAS-STING Pathway

(2021) Julie Constanzo et al.   Frontiers in Immunology

Pharmacological activation of STING blocks SARS-CoV-2 infection

(2021) Minghua Li et al.   Science Immunology

STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype

(2020) Carminia M. Della Corte et al.   Journal of Thoracic Oncology

LXR activation radiosensitizes non-small cell lung cancer by restricting myeloid-derived suppressor cells

(2020) Huaizhen Liang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Pharmacological STING Activation Is a Potential Alternative to Overcome Drug-Resistance in Melanoma

(2020) Sandhya Chipurupalli et al.   Frontiers in Oncology

Old dogs, new trick: classic cancer therapies activate cGAS

(2020) Seoyun Yum et al.   CELL RESEARCH

cGAS-STING pathway in cancer biotherapy

(2020) Yang Wang et al.   Molecular Cancer

Management guidelines for stage III non-small cell lung cancer

(2020) Abdul Rahman Jazieh et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer

(2020) Quinn Storozynsky et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

DNA sensing by the cGAS–STING pathway in health and disease

(2019) Mona Motwani et al.   NATURE REVIEWS GENETICS

Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer

(2019) Kathryn C. Arbour et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

(2019) Narjust Duma et al.   MAYO CLINIC PROCEEDINGS

DNA damage enhancement by radiotherapy-activated hafnium oxide nanoparticles improves cGAS-STING pathway activation in human colorectal cancer cells

(2019) Julie Marill et al.   RADIOTHERAPY AND ONCOLOGY

The Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer

(2019) John Kwon et al.   Cancer Discovery

Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway

(2018) Marco Durante et al.   Frontiers in Oncology

Design of amidobenzimidazole STING receptor agonists with systemic activity

(2018) Joshi M. Ramanjulu et al.   NATURE

The human polynucleotide kinase/phosphatase (hPNKP) inhibitor A12B4C3 radiosensitizes human myeloid leukemia cells to Auger electron-emitting anti-CD123 111In-NLS-7G3 radioimmunoconjugates

(2014) Arman Zereshkian et al.   NUCLEAR MEDICINE AND BIOLOGY